Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Apr 03, 2019 6:22pm
67 Views
Post# 29579045

RE:RE:RE:RE:RE:RE:What happened?

RE:RE:RE:RE:RE:RE:What happened?
skier59 wrote: That's not what I was suggesting. Right-to-Try and the Phase2 FDA are 2 completely different animals. I'm just saying that we have now opened the door to the USA markets because of our successful Phase1b, with the Right-to-Try. With the great success of the Phase1b I think it could be easy to motivate some NMIBC patients in the USA to pay for this treatment. If I were in their skin I certainly would do it. With the ridiculous fees the Big Pharma's charge for their useless pills that generally do very little, TLT looks like a great opportunity to save your bladder. $50,000 is worth the gamble, after all, all the alternatives seem to be useless. Hey we will give you a two year money back guarantee on your 2 treatments. If it doesn't work, you can have your money back. With over 80,000 NMIBC patients in the USA I think we could easily have 1000's of patients lined up. Who the hell would not jump at a money back guarantee on a cancer treatment. Damn we could probably charge $100,000 with that type of guarantee !



I think you are fishing for an easy solution that just isn't there. I don't know about the lining up part as it would end up being a medical procedure for the rich. Not too many average people have $100,000 to blow on a still experimental treatment. The FDA would never allow it nor would the major drug companies who must shell out hundreds of millions to get a drug approved.
Bullboard Posts